Search Login Register

T-Cell Lymphoma (Lymphoma, T Cell) Summary

Description: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.

Also Known As: Lymphoma, T Cell; Lymphoma, T-Cell; Lymphomas, T-Cell; T Cell Lymphoma; T-Cell Lymphomas

Networked: 2570 relevant articles (107 outcomes, 220 trials/studies) for this Disease

Key Drugs and Agents for T-Cell Lymphoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Antibodies : 6 outcomes 9 studies in 81 results : IBA
  2. Doxorubicin (Adriamycin) : 5 outcomes 6 studies in 33 results : FDA 12 Generic
  3. romidepsin (FK228) : 4 outcomes 9 studies in 27 results : FDA 1
  4. alemtuzumab (Campath) : 4 outcomes 6 studies in 23 results : FDA 2
  5. Cyclosporine (Ciclosporin) : 4 outcomes in 26 results : FDA 20 Generic
  6. Paraffin : 3 outcomes 6 studies in 62 results : IBA
  7. Monoclonal Antibodies : 3 outcomes 6 studies in 44 results : IBA
  8. Vincristine (Oncovin) : 3 outcomes 5 studies in 22 results : FDA 17 Generic
  9. 10-propargyl-10-deazaaminopterin : 3 outcomes 5 studies in 14 results : FDA 1
  10. Antigens : 2 outcomes 11 studies in 115 results : IBA
Show All >>

Diseases Related to T-Cell Lymphoma

  1. Neoplasms (Cancer)
  2. Lymphoma (Lymphomas)
  3. B-Cell Lymphoma (Lymphoma, B Cell)
  4. Neoplasm Metastasis (Metastasis)
  5. Carcinoma (Carcinomatosis)
Show All >>

Key Therapies for T-Cell Lymphoma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 19 outcomes 10 studies in 175 results
  2. Radiotherapy : 6 outcomes 6 studies in 59 results
  3. Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) : 5 outcomes in 18 results
  4. Stem Cell Transplantation : 3 outcomes 1 study in 35 results
  5. Transplantation (Transplant Recipients) : 3 outcomes in 48 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.